Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478725
Status:
COMPLETED
Last Update Posted:
2017-11-17
First Post:
2007-05-24
Brief Title:
Part A Radiolabel Study With GW786034 Part B Single Dose of GW786034
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
An Open-Label Two-Part Study to Characterize the Pharmacokinetics of a Single Intravenous Dose of Pazopanib GW786034 and the Absorption Distribution Metabolism and Elimination of a Single Oral 14C Labeled Dose of Pazopanib in Subjects With Solid Tumor Malignancies
Status:
COMPLETED
Status Verified Date:
2017-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the absorption distribution metabolism and excretion of GW786034 and the absorption of a single IV dose of GW786034
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None